KCNIP2: Kv Channel Interacting Protein 2

A key regulator of voltage-gated potassium channels in cardiac and neuronal tissues

Gene Information Card

Symbol KCNIP2
Full Name Potassium Voltage-Gated Channel Interacting Protein 2
Gene Type protein-coding
Chromosomal Location 10q24.32
NCBI Gene ID 30819 ncbi.nlm.nih.gov/gene/30819
Ensembl ID ENSG00000120049
UniProt ID Q9NS61
OMIM ID 604604
HGNC ID 6282
Aliases KChIP2, KCNIP2A, KCNIP2B, KCNIP2C

Description

KCNIP2 encodes a member of the family of voltage-gated potassium (Kv) channel-interacting proteins (KChIPs). This protein binds to the N-terminus of Kv4 alpha subunits, modulating their surface expression, gating kinetics, and inactivation properties. KCNIP2 is highly expressed in the heart and brain, playing a critical role in cardiac repolarization and neuronal excitability.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cardiac arrhythmia (e.g., Brugada syndrome, long QT syndrome) Altered Kv4 channel function due to KCNIP2 variants disrupts cardiac repolarization, increasing arrhythmia risk. ClinVar, OMIM
Epilepsy Dysregulation of Kv4 channels in neurons may contribute to hyperexcitability and seizure susceptibility. NCBI Gene, literature
Atrial fibrillation Reduced KCNIP2 expression in atrial tissue is associated with electrical remodeling and fibrillation. PubMed studies

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 45.2 High
Brain 28.7 Medium
Skeletal muscle 12.3 Low
Pancreas 8.1 Low
Liver 2.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
Cardiomyocytes (iPSC-derived) 52.0 High expression
SH-SY5Y (neuronal) 30.5 Moderate expression
HEK293 1.2 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.458C>T (p.Pro153Leu) Missense <0.01% Reduced Kv4.3 current density; associated with Brugada syndrome (ClinVar)
c.1A>G (p.Met1Val) Start loss <0.01% Loss of protein expression; linked to long QT syndrome (ClinVar)
c.682G>A (p.Glu228Lys) Missense <0.01% Altered channel inactivation; reported in epilepsy (COSMIC)
Mutation functional classification

Loss of Function (LOF)

p.Met1Val and p.Pro153Leu reduce or abolish KCNIP2 protein function, impairing Kv4 channel trafficking and current.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported.

Dominant Negative (DN)

p.Pro153Leu may exert dominant-negative effects by interfering with wild-type KCNIP2 binding to Kv4 subunits.

Pathways

Kv4-mediated potassium channel regulation (Reactome: R-HSA-1296072)
Cardiac conduction (KEGG: hsa05414)
Neuronal system (KEGG: hsa04728)

Protein Summary

KCNIP2 (KChIP2) is a 270-amino acid protein containing four EF-hand calcium-binding domains. It forms a complex with Kv4 alpha subunits (Kv4.2, Kv4.3) to enhance channel surface expression, accelerate recovery from inactivation, and modulate voltage dependence. In the heart, KCNIP2 is essential for the transient outward potassium current (Ito), which shapes the cardiac action potential. In the brain, it regulates dendritic excitability and synaptic plasticity.

Related Products

Product name Cat.No. Species Gene ID
KCNIP2 Knockout HEK293 Cell Line EDJ-KQ9181 Human 30819 Details Get a Quote
KCNIP2 Knockout HCT 116 Cell Line EDJ-KQ35730 Human 30819 Details Get a Quote
KCNIP2 Knockout HeLa Cell Line EDJ-KQ56152 Human 30819 Details Get a Quote
KCNIP2 Knockout A-549 Cell Line EDJ-KQ64642 Human 30819 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: